Literature DB >> 23064855

Hot topics in cardiology: data from IABP-SHOCK II, TRILOGY-ACS, WOEST, ALTIDUDE, FAME II and more.

Christian Ukena1, Michael Böhm, Stephan H Schirmer.   

Abstract

This summary article provides an update on novel clinical trials in the field of cardiovascular medicine which were presented at the annual meeting of the European Cardiac Society, held in Munich, Germany, in August 2012. The data were presented by leading experts in the field with relevant positions in the trials and registries. Unpublished reports should be considered as preliminary data as the analysis may change in the final publications. This article provides the reader with comprehensive summaries of the most recent diagnostic and therapeutic developments in cardiovascular medicine as previously reported (Walenta et al. in Clin Res Cardiol 100:955-971, 2011; Schirmer et al. in Clin Res Cardiol 98:691-699, 2009).

Mesh：

Substances：

Year:  2012        PMID： 23064855     DOI： 10.1007/s00392-012-0511-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


  25 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Vorapaxar in the secondary prevention of atherothrombotic events.

Authors:  David A Morrow; Eugene Braunwald; Marc P Bonaca; Sebastian F Ameriso; Anthony J Dalby; Mary Polly Fish; Keith A A Fox; Leslie J Lipka; Xuan Liu; José Carlos Nicolau; A J Oude Ophuis; Ernesto Paolasso; Benjamin M Scirica; Jindrich Spinar; Pierre Theroux; Stephen D Wiviott; John Strony; Sabina A Murphy
Journal:  N Engl J Med       Date:  2012-03-24       Impact factor: 91.245

3.  The Great East Japan Earthquake Disaster and cardiovascular diseases.

Authors:  Tatsuo Aoki; Yoshihiro Fukumoto; Satoshi Yasuda; Yasuhiko Sakata; Kenta Ito; Jun Takahashi; Satoshi Miyata; Ichiro Tsuji; Hiroaki Shimokawa
Journal:  Eur Heart J       Date:  2012-08-28       Impact factor: 29.983

4.  Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.

Authors:  Benjamin M Scirica; Marc P Bonaca; Eugene Braunwald; Gaetano M De Ferrari; Daniel Isaza; Basil S Lewis; Felix Mehrhof; Piera A Merlini; Sabina A Murphy; Marc S Sabatine; Michal Tendera; Frans Van de Werf; Robert Wilcox; David A Morrow
Journal:  Lancet       Date:  2012-08-26       Impact factor: 79.321

5.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

6.  Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke.

Authors:  Michael Böhm; Daniel Cotton; Lydia Foster; Florian Custodis; Ulrich Laufs; Ralph Sacco; Philip M W Bath; Salim Yusuf; Hans-Christoph Diener
Journal:  Eur Heart J       Date:  2012-08-26       Impact factor: 29.983

7.  Intraaortic balloon support for myocardial infarction with cardiogenic shock.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Henning Ebelt; Steffen Schneider; Gerhard Schuler; Karl Werdan
Journal:  N Engl J Med       Date:  2012-08-26       Impact factor: 91.245

8.  Diagnostic accuracy of fractional flow reserve from anatomic CT angiography.

Authors:  James K Min; Jonathon Leipsic; Michael J Pencina; Daniel S Berman; Bon-Kwon Koo; Carlos van Mieghem; Andrejs Erglis; Fay Y Lin; Allison M Dunning; Patricia Apruzzese; Matthew J Budoff; Jason H Cole; Farouc A Jaffer; Martin B Leon; Jennifer Malpeso; G B John Mancini; Seung-Jung Park; Robert S Schwartz; Leslee J Shaw; Laura Mauri
Journal:  JAMA       Date:  2012-09-26       Impact factor: 56.272

9.  Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study.

Authors:  Jeffrey S Borer; Michael Böhm; Ian Ford; Michel Komajda; Luigi Tavazzi; Jose Lopez Sendon; Marco Alings; Esteban Lopez-de-Sa; Karl Swedberg
Journal:  Eur Heart J       Date:  2012-08-27       Impact factor: 29.983

10.  Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry.

Authors:  Ph Gabriel Steg; Nicola Greenlaw; Jean-Claude Tardif; Michal Tendera; Ian Ford; Stefan Kääb; Hélène Abergel; Kim M Fox; Roberto Ferrari
Journal:  Eur Heart J       Date:  2012-08-26       Impact factor: 29.983
View more
  3 in total

1.  Cardiac magnetic resonance imaging in patients undergoing percutaneous mitral valve repair with the MitraClip system.

Authors:  Patrick Krumm; Christine S Zuern; Thomas H Wurster; Stefanie Mangold; Bernhard D Klumpp; Andreas Henning; Iris I Mueller; Christiane Bretschneider; Axel Bauer; Ulrich Kramer; Andreas E May
Journal:  Clin Res Cardiol       Date:  2014-01-30       Impact factor: 5.460

2.  Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stents.

Authors:  Peter Bramlage; Alessandro Cuneo; Uwe Zeymer; Matthias Hochadel; Gert Richardt; Sigmund Silber; Jochen Senges; Christoph A Nienaber; Ulrich Tebbe; Karl-Heinz Kuck
Journal:  Clin Res Cardiol       Date:  2013-01-05       Impact factor: 5.460

3.  German Heart Report 2013.

Authors:  Thomas Meinertz; Anno Diegeler; Brigitte Stiller; Eckart Fleck; Markus K Heinemann; Achim A Schmaltz; Martin Vestweber; Kurt Bestehorn; Andreas Beckmann; Christian Hamm; Jochen Cremer
Journal:  Clin Res Cardiol       Date:  2015-01-09       Impact factor: 5.460
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.